CLINICAL24: QuidelOrtho’s breakthrough fentanyl solution for the opioid crisis

Join Sonia Nicholas, Managing Editor at SelectScience, as she speaks with Andrew Corkum, Senior Vice President, Global Head of Clinical Labs & Transfusion Medicine Business Units, at QuidelOrtho, about the critical challenges facing the healthcare industry. In this insightful discussion, Andrew highlights QuidelOrtho’s innovative diagnostic solutions, focusing on their rapid fentanyl assay, which provides results in under 10 minutes. Learn how this cutting-edge technology helps combat the opioid crisis by enabling swift clinical decisions, reducing false negatives, and integrating seamlessly into existing healthcare workflows, ultimately saving lives.

This interview was recorded for #CLINICAL24 2024